Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients

Cancer Biology and Therapy

Volumn 14, Issue 12, 2013, Pages 1174-1181

  Kaifi, Jussuf T ^a   Kunkel, Miriam ^b   Zhu, Junjia ^b   Dicker, David T ^b   Gusani, Niraj J ^b   Yang, Zhaohai ^b   Sarwani, Nabeel E ^b   Li, Guangfu ^a   Kimchi, Eric T ^a   Staveley O'Carroll, Kevin F ^a   El Deiry, Wafik S ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b PENN STATE CANCER INSTITUTE   (United States)

Author keywords

Circulating tumor cells; Colorectal cancer; Metastasis

Indexed keywords

B RAF KINASE; CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITHELIAL CELL ADHESION MOLECULE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CIRCULATING TUMOR CELL; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; ONCOGENE N RAS; OVERALL SURVIVAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; VERY ELDERLY; YOUNG ADULT; COLORECTAL TUMOR; LIVER TUMOR; LUNG TUMOR; METABOLISM; PATHOLOGY; SECONDARY; TUMOR EMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; YOUNG ADULT;

EID: 84891782750     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.26884     Document Type: Article

References (26)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277-300; PMID:20610543; http://dx.doi.org/10.3322/caac.20073
2. Chun YS, Vauthey JN. Extending the frontiers of resectability in advanced colorectal cancer. Eur J Surg Oncol 2007; 33(Suppl 2):S52-8; PMID:18006265; http://dx.doi.org/10.1016/j.ejso.2007.09.026 (Pubitemid 350216624)
3. Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 2008; 8:329-40; PMID:18404148; http://dx.doi.org/10.1038/nrc2375 (Pubitemid 351596394)
4. Liu MC, Shields PG, Warren RD, Cohen P, Wilkinson M, Ottaviano YL, Rao SB, Eng-Wong J, Seillier-Moiseiwitsch F, Noone AM, et al. Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. J Clin Oncol 2009; 27:5153-9; PMID:19752342; http://dx.doi.org/10.1200/JCO.2008. 20.6664
5. Hayes DF, Smerage JB. Circulating tumor cells. Prog Mol Biol Transl Sci 2010; 95:95-112; PMID:21075330; http://dx.doi.org/10.1016/B978-0-12-385071-3. 00005-8
6. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008; 26:3213-21; PMID:18591556; http://dx.doi.org/10.1200/JCO.2007.15.8923
7. Lianidou ES, Mavroudis D, Sotiropoulou G, Agelaki S, Pantel K. What's new on circulating tumor cells? A meeting report. Breast Cancer Res 2010; 12:307; PMID:20727231; http://dx.doi.org/10.1186/bcr2601
8. Yu M, Stott S, Toner M, Maheswaran S, Haber DA. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 2011; 192:373-82; PMID:21300848; http://dx.doi.org/10.1083/jcb.201010021
9. Groot Koerkamp B, Rahbari NN, Büchler MW, Koch M, Weitz J. Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis. Ann Surg Oncol 2013; 20:2156-65; PMID:23456317; http://dx.doi.org/10.1245/ s10434-013-2907-8
10. Hashimoto M, Tanaka F, Yoneda K, Kondo N, Takuwa T, Matsumoto S, Kuroda A, Noda M, Tomita N, Hasegawa S. Circulating tumor cells as a potential biomarker in selecting patients for pulmonary metastasectomy from colorectal cancer: report of a case. Case Rep Oncol 2012; 5:542-5; PMID:23139669; http://dx.doi.org/10.1159/000343677
11. Headrick JR, Miller DL, Nagorney DM, Allen MS, Deschamps C, Trastek VF, Pairolero PC. Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg 2001; 71:975-9, discussion 979-80; PMID:11269484; http://dx.doi.org/10.1016/S0003-4975(00)02522-4
12. Aggarwal C, Meropol NJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, et al. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Ann Oncol 2013; 24:420-8; PMID:23028040; http://dx.doi.org/10.1093/ annonc/mds336
13. Lu CY, Uen YH, Tsai HL, Chuang SC, Hou MF, Wu DC, Juo SH, Lin SR, Wang JY. Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse. Br J Cancer 2011; 104:1178-84; PMID:21343933; http://dx.doi.org/10.1038/bjc.2011.40
14. Joosse SA, Pantel K. Biologic challenges in the detection of circulating tumor cells. Cancer Res 2013; 73:8-11; PMID:23271724; http://dx.doi.org/10.1158/ 0008-5472.CAN-12-3422
15. Rahbari NN, Bork U, Kircher A, Nimitz T, Schölch S, Kahlert C, Schmidt T, Steinert G, Ulrich AB, Reissfelder C, et al. Compartmental differences of circulating tumor cells in colorectal cancer. Ann Surg Oncol 2012; 19:2195-202; PMID:22230943; http://dx.doi.org/10.1245/s10434-011-2178-1
16. Jiao LR, Apostolopoulos C, Jacob J, Szydlo R, Johnson N, Tsim N, Habib NA, Coombes RC, Stebbing J. Unique localization of circulating tumor cells in patients with hepatic metastases. J Clin Oncol 2009; 27:6160-5; PMID:19884529; http://dx.doi.org/10.1200/JCO.2009.24.5837
17. Williams A, Balic M, Datar R, Cote R. Sizebased enrichment technologies for CTC detection and characterization. Recent Results Cancer Res 2012; 195:87-95; PMID:22527497; http://dx.doi.org/10.1007/978-3-642-28160-0-8
18. Wicha MS, Hayes DF. Circulating tumor cells: not all detected cells are bad and not all bad cells are detected. J Clin Oncol 2011; 29:1508-11; PMID:21422428; http://dx.doi.org/10.1200/JCO.2010.34.0026
19. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007; 450:1235-9; PMID:18097410; http://dx.doi.org/10.1038/nature06385
20. Lin HK, Zheng S, Williams AJ, Balic M, Groshen S, Scher HI, Fleisher M, Stadler W, Datar RH, Tai YC, et al. Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin Cancer Res 2010; 16:5011-8; PMID:20876796; http://dx.doi.org/10.1158/1078-0432.CCR-10-1105
21. Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med 2008; 14:985-90; PMID:18670422; http://dx.doi.org/10.1038/nm. 1789
22. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351:781-91; PMID:15317891; http://dx.doi.org/10.1056/NEJMoa040766 (Pubitemid 39095313)
23. de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008; 14:6302-9; PMID:18829513; http://dx.doi.org/10. 1158/1078-0432.CCR-08-0872
24. Zhang L, Ridgway LD, Wetzel MD, Ngo J, Yin W, Kumar D, Goodman JC, Groves MD, Marchetti D. The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci Transl Med 2013; 5:80ra48; PMID:23576814; http://dx.doi.org/10.1126/scitranslmed.3005109
25. Mego M, De Giorgi U, Dawood S, Wang X, Valero V, Andreopoulou E, Handy B, Ueno NT, Reuben JM, Cristofanilli M. Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells. Int J Cancer 2011; 129:417-23; PMID:20857493; http://dx.doi.org/10.1002/ijc.25690
26. Gorges TM, Tinhofer I, Drosch M, Röse L, Zollner TM, Krahn T, von Ahsen O. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer 2012; 12:178; PMID:22591372; http://dx.doi.org/10.1186/1471-2407-12-178